nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP26B1—schizophrenia	0.00576	0.00576	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—schizophrenia	0.00568	0.00568	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—CCKAR—schizophrenia	0.00562	0.00562	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—NTS—schizophrenia	0.00551	0.00551	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—ADORA2A—schizophrenia	0.00545	0.00545	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—schizophrenia	0.00538	0.00538	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—schizophrenia	0.00528	0.00528	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—GRM3—schizophrenia	0.00518	0.00518	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HTR6—schizophrenia	0.00509	0.00509	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCK—schizophrenia	0.00502	0.00502	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—HTR1B—schizophrenia	0.00491	0.00491	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCKAR—schizophrenia	0.00481	0.00481	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP26B1—schizophrenia	0.00473	0.00473	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—HTR1A—schizophrenia	0.00473	0.00473	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADORA2A—schizophrenia	0.00467	0.00467	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2C—schizophrenia	0.00456	0.00456	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—DRD1—schizophrenia	0.00456	0.00456	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CHRM1—schizophrenia	0.00449	0.00449	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—schizophrenia	0.00449	0.00449	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—DRD3—schizophrenia	0.00442	0.00442	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	0.00436	0.00436	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—DGKI—schizophrenia	0.00431	0.00431	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—DRD4—schizophrenia	0.00429	0.00429	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	0.00421	0.00421	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	0.00421	0.00421	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—GRM5—schizophrenia	0.00418	0.00418	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—CNR1—schizophrenia	0.0041	0.0041	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	0.00405	0.00405	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—HTR7—schizophrenia	0.004	0.004	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—DRD2—schizophrenia	0.004	0.004	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	0.00399	0.00399	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—DGKI—schizophrenia	0.00391	0.00391	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.00391	0.00391	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	0.00391	0.00391	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCK—schizophrenia	0.00382	0.00382	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.00379	0.00379	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—schizophrenia	0.00372	0.00372	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.00368	0.00368	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCKAR—schizophrenia	0.00366	0.00366	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—HTR2A—schizophrenia	0.00362	0.00362	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—NDST3—schizophrenia	0.00362	0.00362	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PPP1R1B—schizophrenia	0.00358	0.00358	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—ADORA2A—schizophrenia	0.00355	0.00355	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—schizophrenia	0.00355	0.00355	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.00351	0.00351	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—TAAR6—schizophrenia	0.00345	0.00345	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GRM2—schizophrenia	0.00345	0.00345	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	0.00342	0.00342	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.00342	0.00342	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—FZD3—schizophrenia	0.00333	0.00333	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—NPY—schizophrenia	0.00332	0.00332	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—CYP1A2—schizophrenia	0.0033	0.0033	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—schizophrenia	0.00324	0.00324	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HTR1B—schizophrenia	0.0032	0.0032	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—OXT—schizophrenia	0.0032	0.0032	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—NGEF—schizophrenia	0.00319	0.00319	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—schizophrenia	0.00315	0.00315	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PPP3CC—schizophrenia	0.00313	0.00313	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GRM2—schizophrenia	0.00313	0.00313	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—TAAR6—schizophrenia	0.00313	0.00313	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—NTS—schizophrenia	0.00312	0.00312	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—schizophrenia	0.00311	0.00311	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HTR1A—schizophrenia	0.00308	0.00308	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—NPS—schizophrenia	0.00304	0.00304	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—DRD1—schizophrenia	0.00298	0.00298	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HTR2C—schizophrenia	0.00298	0.00298	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—RGS4—schizophrenia	0.00293	0.00293	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GRM3—schizophrenia	0.00293	0.00293	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NGEF—schizophrenia	0.0029	0.0029	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—DRD3—schizophrenia	0.00288	0.00288	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HTR6—schizophrenia	0.00288	0.00288	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—schizophrenia	0.00285	0.00285	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NTS—schizophrenia	0.00283	0.00283	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—schizophrenia	0.00281	0.00281	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	0.0028	0.0028	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—DRD4—schizophrenia	0.0028	0.0028	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—AKT1—schizophrenia	0.00277	0.00277	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CNR1—schizophrenia	0.00267	0.00267	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GRM3—schizophrenia	0.00266	0.00266	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—RGS4—schizophrenia	0.00266	0.00266	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR6—schizophrenia	0.00261	0.00261	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HTR7—schizophrenia	0.00261	0.00261	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—DRD2—schizophrenia	0.00261	0.00261	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	0.00256	0.00256	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CHRM1—schizophrenia	0.00254	0.00254	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PLA2G4A—schizophrenia	0.00253	0.00253	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP26B1—schizophrenia	0.00251	0.00251	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP26B1—schizophrenia	0.00248	0.00248	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL3RA—schizophrenia	0.00248	0.00248	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.0024	0.0024	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GRM5—schizophrenia	0.00236	0.00236	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	0.00231	0.00231	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DGKI—schizophrenia	0.00231	0.00231	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CHRM1—schizophrenia	0.00231	0.00231	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL3RA—schizophrenia	0.00225	0.00225	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GCLM—schizophrenia	0.00224	0.00224	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCK—schizophrenia	0.00216	0.00216	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GRM5—schizophrenia	0.00214	0.00214	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PPP1R1B—schizophrenia	0.00211	0.00211	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PDE4B—schizophrenia	0.0021	0.0021	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCKAR—schizophrenia	0.00207	0.00207	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—ADORA2A—schizophrenia	0.00201	0.00201	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FZD3—schizophrenia	0.00197	0.00197	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCK—schizophrenia	0.00196	0.00196	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	0.00192	0.00192	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PDE4B—schizophrenia	0.00191	0.00191	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCKAR—schizophrenia	0.00188	0.00188	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—NPY—schizophrenia	0.00188	0.00188	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRM2—schizophrenia	0.00185	0.00185	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PPP3CC—schizophrenia	0.00185	0.00185	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FES—schizophrenia	0.00185	0.00185	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TAAR6—schizophrenia	0.00185	0.00185	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HTR2A—schizophrenia	0.00183	0.00183	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ADORA2A—schizophrenia	0.00182	0.00182	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HTR1B—schizophrenia	0.00181	0.00181	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—OXT—schizophrenia	0.00181	0.00181	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HTR1A—schizophrenia	0.00174	0.00174	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—NPS—schizophrenia	0.00172	0.00172	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NGEF—schizophrenia	0.00171	0.00171	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NPY—schizophrenia	0.0017	0.0017	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—DRD1—schizophrenia	0.00168	0.00168	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HTR2C—schizophrenia	0.00168	0.00168	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NTS—schizophrenia	0.00167	0.00167	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—OXT—schizophrenia	0.00164	0.00164	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR1B—schizophrenia	0.00164	0.00164	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—DRD3—schizophrenia	0.00163	0.00163	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR1A—schizophrenia	0.00158	0.00158	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—DRD4—schizophrenia	0.00158	0.00158	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRM3—schizophrenia	0.00157	0.00157	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RGS4—schizophrenia	0.00157	0.00157	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RTN4—schizophrenia	0.00157	0.00157	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NPS—schizophrenia	0.00156	0.00156	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR6—schizophrenia	0.00154	0.00154	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—DRD1—schizophrenia	0.00153	0.00153	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR2C—schizophrenia	0.00153	0.00153	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CNR1—schizophrenia	0.00151	0.00151	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAG—schizophrenia	0.00149	0.00149	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—DRD3—schizophrenia	0.00148	0.00148	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—DRD2—schizophrenia	0.00147	0.00147	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HTR7—schizophrenia	0.00147	0.00147	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—DRD4—schizophrenia	0.00144	0.00144	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CNR1—schizophrenia	0.00137	0.00137	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CHRM1—schizophrenia	0.00136	0.00136	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP2D6—schizophrenia	0.00136	0.00136	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP2D6—schizophrenia	0.00134	0.00134	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR7—schizophrenia	0.00134	0.00134	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—DRD2—schizophrenia	0.00134	0.00134	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ACSL6—schizophrenia	0.00134	0.00134	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SLC27A5—schizophrenia	0.00134	0.00134	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL3RA—schizophrenia	0.00133	0.00133	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NRG3—schizophrenia	0.0013	0.0013	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TLE1—schizophrenia	0.0013	0.0013	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GFAP—schizophrenia	0.00128	0.00128	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRM5—schizophrenia	0.00127	0.00127	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP1A2—schizophrenia	0.00123	0.00123	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TLE3—schizophrenia	0.00123	0.00123	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP1A2—schizophrenia	0.00121	0.00121	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCK—schizophrenia	0.00116	0.00116	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDE4B—schizophrenia	0.00113	0.00113	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCKAR—schizophrenia	0.00111	0.00111	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADORA2A—schizophrenia	0.00108	0.00108	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—schizophrenia	0.00107	0.00107	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PLA2G4A—schizophrenia	0.00106	0.00106	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGA—schizophrenia	0.00103	0.00103	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HTR2A—schizophrenia	0.00103	0.00103	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—COMT—schizophrenia	0.00103	0.00103	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTP1—schizophrenia	0.00102	0.00102	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—MAOA—schizophrenia	0.00102	0.00102	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—COMT—schizophrenia	0.00102	0.00102	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTP1—schizophrenia	0.00101	0.00101	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NPY—schizophrenia	0.00101	0.00101	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOTCH4—schizophrenia	0.00101	0.00101	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ATP2A2—schizophrenia	0.00101	0.00101	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR1B—schizophrenia	0.000971	0.000971	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—OXT—schizophrenia	0.000971	0.000971	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTM1—schizophrenia	0.000941	0.000941	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR2A—schizophrenia	0.000937	0.000937	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR1A—schizophrenia	0.000935	0.000935	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTM1—schizophrenia	0.000928	0.000928	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NPS—schizophrenia	0.00092	0.00092	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DRD1—schizophrenia	0.000903	0.000903	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR2C—schizophrenia	0.000903	0.000903	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PRODH—schizophrenia	0.000881	0.000881	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NTRK2—schizophrenia	0.000878	0.000878	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DRD3—schizophrenia	0.000874	0.000874	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DRD4—schizophrenia	0.000849	0.000849	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CNR1—schizophrenia	0.00081	0.00081	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	0.000809	0.000809	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DRD2—schizophrenia	0.000791	0.000791	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR7—schizophrenia	0.000791	0.000791	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRL—schizophrenia	0.000747	0.000747	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MPC2—schizophrenia	0.000718	0.000718	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—S100B—schizophrenia	0.000696	0.000696	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	0.000669	0.000669	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLCH2—schizophrenia	0.000667	0.000667	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ERBB4—schizophrenia	0.000665	0.000665	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NDST3—schizophrenia	0.000628	0.000628	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PLA2G4A—schizophrenia	0.000626	0.000626	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NRG1—schizophrenia	0.000614	0.000614	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MEF2C—schizophrenia	0.000609	0.000609	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ACSL6—schizophrenia	0.000595	0.000595	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC27A5—schizophrenia	0.000595	0.000595	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—YWHAZ—schizophrenia	0.000588	0.000588	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	0.000581	0.000581	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ERBB3—schizophrenia	0.000575	0.000575	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—DAO—schizophrenia	0.000568	0.000568	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR2A—schizophrenia	0.000554	0.000554	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PNP—schizophrenia	0.000544	0.000544	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APOE—schizophrenia	0.000515	0.000515	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APOA1—schizophrenia	0.000509	0.000509	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NDUFV2—schizophrenia	0.000506	0.000506	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ESR1—schizophrenia	0.000491	0.000491	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIP4K2A—schizophrenia	0.000476	0.000476	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	0.000472	0.000472	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GSK3B—schizophrenia	0.000446	0.000446	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP26B1—schizophrenia	0.00043	0.00043	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TPH1—schizophrenia	0.000383	0.000383	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GCLM—schizophrenia	0.000383	0.000383	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	0.000361	0.000361	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PRKD1—schizophrenia	0.00036	0.00036	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKT1—schizophrenia	0.00033	0.00033	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GAPDH—schizophrenia	0.000301	0.000301	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKT1—schizophrenia	0.0003	0.0003	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CLOCK—schizophrenia	0.000298	0.000298	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—schizophrenia	0.000297	0.000297	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	0.000294	0.000294	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EP300—schizophrenia	0.000293	0.000293	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TPH2—schizophrenia	0.000291	0.000291	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CACNB2—schizophrenia	0.000291	0.000291	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—DPYD—schizophrenia	0.000286	0.000286	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CACNA1C—schizophrenia	0.000266	0.000266	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3C2A—schizophrenia	0.000259	0.000259	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2D6—schizophrenia	0.000232	0.000232	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SNAP25—schizophrenia	0.000232	0.000232	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP1A2—schizophrenia	0.00021	0.00021	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TP53—schizophrenia	0.00021	0.00021	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TH—schizophrenia	0.000207	0.000207	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKT1—schizophrenia	0.000177	0.000177	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—COMT—schizophrenia	0.000176	0.000176	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTP1—schizophrenia	0.000175	0.000175	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MAOA—schizophrenia	0.000175	0.000175	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	0.000169	0.000169	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCB1—schizophrenia	0.000166	0.000166	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLA2G4A—schizophrenia	0.000161	0.000161	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTM1—schizophrenia	0.000161	0.000161	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MTHFR—schizophrenia	0.000142	0.000142	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—APOE—schizophrenia	0.000132	0.000132	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—APOA1—schizophrenia	0.000131	0.000131	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—EP300—schizophrenia	7.55e-05	7.55e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AKT1—schizophrenia	4.56e-05	4.56e-05	CbGpPWpGaD
